X-133754180-T-TA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_004484.4(GPC3):​c.338-5dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 23 hom., 186 hem., cov: 19)
Exomes 𝑓: 0.076 ( 1 hom. 18 hem. )

Consequence

GPC3
NM_004484.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.883

Publications

7 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-133754180-T-TA is Benign according to our data. Variant chrX-133754180-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 695314.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0171 (1305/76406) while in subpopulation AFR AF = 0.0461 (951/20630). AF 95% confidence interval is 0.0437. There are 23 homozygotes in GnomAd4. There are 186 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPC3NM_004484.4 linkc.338-5dupT splice_region_variant, intron_variant Intron 2 of 7 ENST00000370818.8 NP_004475.1 P51654-1Q53H15I6QTG3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkc.338-5_338-4insT splice_region_variant, intron_variant Intron 2 of 7 1 NM_004484.4 ENSP00000359854.3 P51654-1

Frequencies

GnomAD3 genomes
AF:
0.0171
AC:
1308
AN:
76415
Hom.:
23
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.0463
Gnomad AMI
AF:
0.00866
Gnomad AMR
AF:
0.00497
Gnomad ASJ
AF:
0.00257
Gnomad EAS
AF:
0.00345
Gnomad SAS
AF:
0.00177
Gnomad FIN
AF:
0.0110
Gnomad MID
AF:
0.00704
Gnomad NFE
AF:
0.00667
Gnomad OTH
AF:
0.0121
GnomAD2 exomes
AF:
0.0845
AC:
6102
AN:
72176
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.116
Gnomad AMR exome
AF:
0.0557
Gnomad ASJ exome
AF:
0.106
Gnomad EAS exome
AF:
0.103
Gnomad FIN exome
AF:
0.0788
Gnomad NFE exome
AF:
0.0806
Gnomad OTH exome
AF:
0.0918
GnomAD4 exome
AF:
0.0761
AC:
59912
AN:
787248
Hom.:
1
Cov.:
0
AF XY:
0.0000922
AC XY:
18
AN XY:
195282
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0929
AC:
1733
AN:
18655
American (AMR)
AF:
0.0381
AC:
951
AN:
24986
Ashkenazi Jewish (ASJ)
AF:
0.0668
AC:
1010
AN:
15120
East Asian (EAS)
AF:
0.0562
AC:
1429
AN:
25423
South Asian (SAS)
AF:
0.0514
AC:
1908
AN:
37129
European-Finnish (FIN)
AF:
0.0524
AC:
1563
AN:
29842
Middle Eastern (MID)
AF:
0.0506
AC:
142
AN:
2804
European-Non Finnish (NFE)
AF:
0.0813
AC:
48682
AN:
598847
Other (OTH)
AF:
0.0724
AC:
2494
AN:
34442
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.304
Heterozygous variant carriers
0
4392
8785
13177
17570
21962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2076
4152
6228
8304
10380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0171
AC:
1305
AN:
76406
Hom.:
23
Cov.:
19
AF XY:
0.0104
AC XY:
186
AN XY:
17820
show subpopulations
African (AFR)
AF:
0.0461
AC:
951
AN:
20630
American (AMR)
AF:
0.00497
AC:
36
AN:
7245
Ashkenazi Jewish (ASJ)
AF:
0.00257
AC:
5
AN:
1946
East Asian (EAS)
AF:
0.00308
AC:
8
AN:
2597
South Asian (SAS)
AF:
0.00179
AC:
3
AN:
1679
European-Finnish (FIN)
AF:
0.0110
AC:
31
AN:
2824
Middle Eastern (MID)
AF:
0.00806
AC:
1
AN:
124
European-Non Finnish (NFE)
AF:
0.00668
AC:
253
AN:
37899
Other (OTH)
AF:
0.0130
AC:
13
AN:
1000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
46
93
139
186
232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0332
Hom.:
71

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Feb 24, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Wilms tumor 1 Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Jan 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370737647; hg19: chrX-132888207; COSMIC: COSV63665302; COSMIC: COSV63665302; API